Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Ophthalmology

Standard Treatment: Bridging to Surgery

At a Glance

Phacogenic glaucoma is usually stabilized with closely monitored pressure-lowering medicines and inflammation treatment, but these measures are temporary. Removing the swollen, damaged, or leaking lens is the definitive treatment, often performed urgently to protect vision.

The definitive “cure” for the lens-induced component of your glaucoma is straightforward: the problematic lens must be removed [1]. However, performing surgery when eye pressure is extremely high—often 40 to 60 mmHg—is dangerous. High pressure makes the eye more prone to serious complications during surgery, such as bleeding or sudden shifts in internal structures [2].

Because of this, your medical team will use a medical bridge strategy. The goal is to lower your eye pressure and calm inflammation quickly to create a safer environment for the surgeon [3][4].

The Patient Pathway

  1. Emergency Assessment: Recognizing the high pressure and diagnosing the lens as the cause.
  2. Medical Bridge: Using intensive, doctor-supervised medications to rapidly lower pressure.
  3. Urgent Surgery: Removing the lens (cataract extraction).
  4. Post-Op Monitoring: Watching for pressure changes and managing any remaining glaucoma.

The Medical Bridge: Lowering Pressure

To stabilize your eye, doctors use a combination of powerful medications that work in different ways. These medications must be carefully selected and monitored by an ophthalmologist, as they have important systemic effects:

  • Topical Aqueous Suppressants: These are eye drops that tell your eye to produce less fluid. Common classes include beta-blockers (which may be problematic if you have certain heart or lung conditions) and alpha-agonists [5].
  • Systemic Carbonic Anhydrase Inhibitors: Medications like acetazolamide (Diamox) are often given as a pill or through an IV. They reduce fluid production but require your doctor to check for kidney issues or sulfa allergies [3].
  • Hyperosmotic Agents: In severe cases, you may receive IV mannitol. This medication works like a “chemical sponge,” pulling excess fluid out of the eye and into the bloodstream, but it requires careful fluid-balance and cardiac monitoring [3].

Crucially: Never start, borrow, stop, or adjust these medicines on your own. Provide your care team with a complete list of all your current medical conditions and medications.

Why Certain Medications are Avoided

In phacomorphic glaucoma (where the lens is swollen), a common glaucoma medication called pilocarpine is generally avoided. While pilocarpine can help in other types of glaucoma, in phacomorphic cases, it constricts the pupil. This can pull the iris into even tighter contact with the already swollen lens, potentially narrowing the drainage angle further [6][7].

Managing Inflammation

If your diagnosis is phacolytic or phacoantigenic glaucoma, inflammation is a major driver of your high pressure. Your doctor may prescribe:

  • Topical Corticosteroids: These drops reduce the immune response and clear the “clog” of inflammatory cells. However, steroids can raise eye pressure or be dangerous if an infection hasn’t been ruled out, so they are used under strict supervision [8][9].
  • Cycloplegic Drops: These drops dilate the pupil and relax the muscles inside the eye to reduce pain, though they may be inappropriate in eyes with very crowded, closed drainage angles [8].

The Definitive Fix: Surgery

Once your eye pressure is stabilized, you will undergo cataract extraction or a lensectomy [4].

Timing is highly individualized. While many clinicians prefer to lower the pressure and operate within hours or a few days, the medical bridge is only temporary. It must not delay definitive treatment indefinitely. If medications fail to bring the pressure down, your surgeon may need to proceed with same-day or very early surgery to save the optic nerve [3][4].

Removing the lens resolves the primary trigger for the glaucoma, and many patients achieve normal eye pressure after recovery [10][11]. However, the “medical bridge” is only a stepping stone to surgery, and long-term monitoring will determine if any permanent glaucoma damage remains [12].

Common questions in this guide

Why are eye-pressure medicines given before surgery for phacogenic glaucoma?
Very high eye pressure can make lens-removal surgery more dangerous by increasing the risk of bleeding and sudden shifts inside the eye. Doctors use a short-term combination of medicines to lower pressure and calm inflammation, creating a safer setting for surgery.
What medicines may quickly lower pressure in phacogenic glaucoma?
Treatment may include pressure-lowering eye drops, acetazolamide by mouth or through an IV, and, in severe cases, IV mannitol. The combination depends on your eye pressure and overall health. An ophthalmologist must consider kidney, heart, lung, fluid-balance, and sulfa-allergy concerns when selecting and monitoring these medicines.
How soon is cataract surgery done after treatment for phacogenic glaucoma begins?
The medicines are a temporary bridge, not a replacement for lens removal. Many clinicians aim for surgery within hours to a few days after pressure is brought under control; if medicines do not lower pressure enough, same-day or very early surgery may be needed to protect the optic nerve.
Why is pilocarpine usually avoided in phacomorphic glaucoma?
Pilocarpine constricts the pupil. When the lens is swollen, this can pull the iris into closer contact with the lens and narrow the eye’s drainage angle further, potentially worsening the pressure problem.
Will glaucoma go away after the affected lens is removed?
Removing the lens treats the main trigger, and many patients have normal eye pressure after recovery. Long-term monitoring is still needed because some people have persistent glaucoma or optic nerve damage and may need ongoing treatment.

Get notified when new evidence is published on phacogenic glaucoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    Outcomes and Reasons for Late Presentation of Lens Induced Glaucoma: A Prospective Study.

    Ayub R, Tom LM, Venkatesh R, Srinivasan K

    Ophthalmology. Glaucoma 2021; (4(5)):504-511 doi:10.1016/j.ogla.2021.01.005.

    PMID: 33548550
  2. 2

    Rare atypical presentation of phacolytic glaucoma as non-resolving microbial keratitis with endophthalmitis.

    Agarwal R, Tripathi M, Patil A, Sharma N

    BMJ case reports 2019; (12(9)) doi:10.1136/bcr-2019-231616.

    PMID: 31527222
  3. 3

    Phacomorphic Angle-closure Following Silicone Oil Tamponade in a Pediatric Patient.

    Leung VC, Fung SSM, Muni R, Ali A

    Journal of glaucoma 2018; (27(6)):e106-e109 doi:10.1097/IJG.0000000000000957.

    PMID: 29613981
  4. 4

    Intraoperative Descemet's membrane detachment in a case of phacomorphic glaucoma.

    Pujari A, Swamy DR, Chaniyara MH, Sharma N

    BMJ case reports 2018; (2018()) doi:10.1136/bcr-2018-225593.

    PMID: 30344145
  5. 5

    [Angle-closure glaucoma].

    Krzyzanowska I, Töteberg-Harms M

    Die Ophthalmologie 2022; (119(11)):1167-1179 doi:10.1007/s00347-022-01745-w.

    PMID: 36303042
  6. 6

    Post-miosis changes in the anterior chamber structures in primary and lens-induced secondary chronic angle-closure glaucoma.

    Li M, Yan XQ, Li GY, Zhang H

    International journal of ophthalmology 2019; (12(4)):675-680 doi:10.18240/ijo.2019.04.24.

    PMID: 31024825
  7. 7

    Comparison of ultrasound biomicroscopy and ultrasonographic parameters in eyes with phacomorphic glaucoma and eyes with mature cataract.

    Subbiah S, Thomas PA, Nelson Jesudasan CA

    International ophthalmology 2017; (37(4)):849-858 doi:10.1007/s10792-016-0343-z.

    PMID: 27624171
  8. 8

    Retrolental Opacity: Atypical Manifestation of Lens-Induced Uveitis.

    Lopez-Zuñiga DI, Ibarra-Salazar N, Gonzalez-Godinez S, Garza-Duron R

    Cureus 2025; (17(9)):e93053 doi:10.7759/cureus.93053.

    PMID: 40994763
  9. 9

    Lens-Induced Uveitis: A Systematic Review of Pathophysiology, Diagnosis, and Treatment.

    Rodríguez-Malagón ME, Salazar-Vitale A, Cantón-Muñiz NM, et al.

    Seminars in ophthalmology 2026; (41(7)):808-818 doi:10.1080/08820538.2026.2670454.

    PMID: 42102317
  10. 10

    Comparison of Cataract Surgery Alone Versus Cataract Surgery Combined With Trabeculectomy in the Management of Phacomorphic Glaucoma.

    Senthil S, Chinta S, Rao HL, et al.

    Journal of glaucoma 2016; (25(3)):e209-13 doi:10.1097/IJG.0000000000000229.

    PMID: 25642811
  11. 11

    Phacoemulsification in phacomorphic angle closure: Our experience.

    Farooq S, Khan NA, Meena R, Kochar A

    Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society 2023; (37(2)):90-93 doi:10.4103/sjopt.sjopt_38_22.

    PMID: 37492207
  12. 12

    Outcomes and favourable prognostic factors in patients of phacomorphic and phacolytic glaucoma managed by manual small-incision cataract surgery: A retrospective study.

    Chandrashekharan S, Chakrabarty S, Tanwar M, et al.

    Indian journal of ophthalmology 2022; (70(4)):1216-1221 doi:10.4103/ijo.IJO_2371_21.

    PMID: 35326019

This page is for informational purposes only and does not constitute medical advice. Because phacogenic glaucoma can threaten vision quickly, an ophthalmologist should direct medication choices, monitoring, and the timing of lens-removal surgery.